IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Founders Fund VI Management, LLC

Q4 2023 Holdings

Filed 2024-02-14 | 2 holdings | $12.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Roivant Sciences LTD(ROIV)SHSG76279101$12.6M1,119,48998.6%
Cyclo Therapeutics IncCOM NEW23254X201$174.9K110,0231.4%